A new mRNA-based vaccine offers significant promise in both treating and preventing the highly contagious and notoriously difficult-to-treat Clostridioides difficile (C. difficile) infection, also known as C. diff. In...
Researchers from several U.S. institutions have developed an mRNA vaccine that has proven effective in protecting mice against intestinal Clostridioides difficile bacterial infections. In their paper published in...
Although leukocytosis is a prognostic marker in patients with Clostridium difficile (C difficile) infection, it is not an independent predictor of a positive nucleic acid amplification test (NAAT) result for...